查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1941583

人工角膜和角膜植入市场规模、份额、趋势和预测（按类型、植入物类型、疾病适应症、最终用户和地区划分），2026-2034年

Artificial Cornea and Corneal Implant Market Size, Share, Trends and Forecast by Type, Transplant Type, Disease Indication, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 136 Pages | 商品交期: 2-3个工作天内

价格

2025年全球人工角膜和角膜植入市场规模为4.982亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到8.552亿美元，2026年至2034年的复合年增长率（CAGR）为6.00%。目前，北美市场占据主导地位，市占率高达50.5%。角膜感染疾病和眼部疾病的日益普遍、各类医疗设施建设的不断增加以及对穿透性角膜移植需求的增长是推动市场发展的主要因素。

目前，对人工角膜和角膜植入市场产生积极影响的主要因素之一是一般人群中角膜感染疾病和眼部疾病发生率的不断上升。根据PubMed Central统计，全球约有600万人患有角膜混浊，使其成为失明和视力障碍的第六大原因。此外，包括医院、疗养院和眼科诊所在内的医疗设施的扩建，能够更有效地治疗患者，也提振了市场前景。年轻人口的成长，以及他们因使用电脑、笔记型电脑和长时间盯着智慧型手机而导致的视力问题日益增多，也促进了市场扩张。根据加泰隆尼亚视网膜研究所估计，18至40岁的男性约占眼部外伤病例的75%。此外，全球人口老化导致对穿透性角膜移植的需求不断增长，也推动了市场扩张。

美国是推动市场成长的关键因素之一，占北美市场90.20%的份额。角膜疾病是美国导致视力障碍的主要原因。根据美国疾病管制与预防中心（CDC）统计，角膜问题是导致视力丧失和失明的主要原因，影响超过700万美国人。此外，由于需求不断增长，目前正在努力增加角膜移植的供应。 2023年，共从69,637名捐赠者身上取得了137,697例组织，比2022年成长了12.8%。然而，角膜移植的需求成长速度仍超过捐赠组织的供应速度，凸显了植入和人工角膜等替代方案的必要性。

人工角膜和角膜植入市场趋势：

医疗成本不断上涨和先进治疗手段的普及

世界各地的医疗卫生系统都在优先发展眼科保健，并投入更多资源用于治疗方法和研发解决视力障碍的技术。例如，美国政府已向疾病管制与预防中心（CDC）的视力与眼部保健计画拨款650万美元。其中，视力健康倡议（VHI）基金在2023财年的预算增加了250万美元，比2022财年增加了100万美元。已开发国家和新兴国家不断增加的医疗卫生预算正在扩大先进治疗手段的覆盖范围，包括人工角膜和植入。各国政府、私立医院和非政府组织正积极努力，使更多患者，特别是医疗资源匮乏地区的患者，能够获得这些创新技术。

老龄人口快速成长

推动这一市场发展的关键因素之一是人口老化。角膜混浊和内皮功能障碍等退化性眼科疾病在老年族群中较常见。随着全球预期寿命的延长，需要进行视力恢復手术的人数也不断增加。在美国，约有1200万40岁及以上的成年人患有视力障碍。一项研究预测，由于都市化、人口老化和人口成长，到2050年，残障人士人数将达到约8.95亿，其中6,100万人将失明。对于老年患者，尤其是那些因健康原因无法接受传统移植手术的患者而言，人工角膜和角膜植入提供了可靠的替代方案。

提高公众意识并推广先进的视觉解决方案

提高大众对眼部健康以及人工角膜和植入益处的认知，在推动市场成长方面发挥关键作用。患者和医疗专业人员对这些先进解决方案的了解日益增多，从而提高了接受度和普及率。专注于视力保健的机构正利用媒体平台、社区宣传活动和教育计画来传播相关知识。随着患者了解了诸如改善视觉品质和降低风险等长期益处，他们选择接受这些手术的人数也不断增加。这种认知的提升正在带动需求的成长，尤其是在传统眼科医疗服务不足的地区。

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 次要讯息
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 调查方法

第三章执行摘要

第四章 引言

5. 全球人工角膜和角膜植入市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 按类型分類的市场区隔

  • 人类角膜
  • 人工角膜

7. 按移植类型分類的市场细分

  • 穿孔性角膜移植术
  • 内皮角膜移植手术
  • 前角膜移植
  • 人工替代物

第八章 依疾病适应症分類的市场区隔

  • 福克斯角膜营养不良
  • 霉菌性角膜炎
  • 圆锥角膜
  • 其他的

第九章 依最终用户分類的市场细分

  • 医院
  • 门诊手术中心
  • 专科诊所

第十章 按地区分類的市场细分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十一章 SWOT 分析

第十二章 价值链分析

第十三章 波特五力分析

第十四章：定价分析

第十五章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • AJL Ophthalmic SA
    • CorNeat Vision
    • Eye Care of San Diego
    • EyeYon Medical
    • KeraMed, Inc
    • LinkoCare Life Sciences AB
    • Lions World Vision Institute
    • LJ Eye Institute
    • Lv Prasad Eye Institute
Product Code: SR112026A4961

The global artificial cornea and corneal implant market size was valued at USD 498.2 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 855.2 Million by 2034, exhibiting a CAGR of 6.00% during 2026-2034. North America currently dominates the market with a market share of 50.5%. The growing prevalence of corneal infections and eye-associated disorders, rising construction of various healthcare facilities, and escalating demand for full-thickness corneal transplantation represent some of the key factors driving the market.

Currently, one of the main factors favorably impacting the artificial corneas and corneal implants market is the increased incidence of corneal infections and eye-related conditions in the general population. About 6 million individuals worldwide suffer from corneal opacity, which ranks as the sixth most common cause of blindness and visual impairment, according to PubMed Central. In addition, a positive market outlook is being provided by the expanding construction of healthcare facilities, including hospitals, assisted living facilities, and eye clinics, in order to effectively treat patients. Additionally, the market is expanding because of the growing prevalence of vision issues among young people who spend a lot of time using computers and laptops or staring at smartphones. The Institut Catala de Retina estimates that men between the ages of 18 and 40 account for around 75% of eye injuries. In addition, the market is expanding as a result of the growing need for full-thickness corneal transplantation brought on by the world's aging population.

One significant disruptor of the market is the United States with a market share of 90.20% in North America. In the nation, corneal disorders have been a major cause of vision impairment. According to the Centers for Disease Control and Prevention (CDC), corneal problems are a major cause of vision loss or blindness, which affects over 7 million Americans. Furthermore, the nation has been having trouble keeping up with the demand for corneal transplants, with initiatives to boost contributions. With a 12.8% increase in donors over 2022, eye banks reported 137,697 tissue recoveries from 69,637 donors in 2023. Nevertheless, the demand for corneal transplants keeps rising faster than the supply of donor tissue, highlighting the need for substitutes such as implants and artificial corneas.

Artificial Cornea and Corneal Implant Market Trends:

Rising Healthcare Expenditure and Access to Advanced Treatments

Healthcare systems worldwide are prioritizing eye health, and allocating more resources to treatments and technologies that address visual impairments. For instance, the government of USA allocated a total of $6.5 million for vision and eye health programs at the Centers for Disease Control and Prevention (CDC). In particular, the fund Vision Health Initiative (VHI) saw a budget increase of $2.5 million in FY2023, a $1 million hike over FY2022. Rising healthcare budgets in both developed and emerging economies are enabling greater access to advanced treatments, including artificial corneas and implants. Governments, private hospitals, and non-governmental organizations are actively working to make these innovations available to more patients, particularly in underserved regions.

Surge in Geriatric Population

One of the key factors propelling this market is the aging population. Degenerative eye diseases such corneal opacities and endothelial dysfunction are more common in older persons. The number of people in need of vision restoration operations is increasing as a result of rising life expectancy worldwide. In the United States, almost 12 million adults over 40 suffer from a visual impairment. According to a study, by 2050, there may be around 895 million individuals with distant vision impairment, of whom 61 million will be blind, as a result of urbanization, aging, and population expansion. For older patients, particularly those who are unable to get conventional transplants because of health issues, artificial corneas and corneal implants provide a dependable alternative.

Increasing Awareness and Adoption of Advanced Vision Solutions

Awareness campaigns about eye health and the benefits of artificial corneas and implants are playing a pivotal role in driving market growth. Patients and healthcare providers are becoming more informed about these cutting-edge solutions, leading to increased acceptance and adoption. Organizations focused on vision care are leveraging media platforms, community outreach programs, and educational initiatives to spread knowledge. As patients learn about the long-term benefits, including improved vision quality and reduced risks, more are opting for these procedures. This growing awareness is translating into higher demand, particularly in regions where traditional eye care methods are less effective.

Artificial Cornea and Corneal Implant Industry Segmentation:

Analysis by Type:

  • Human Cornea
  • Artificial Cornea

Human cornea accounts for the largest market share in 2025. This growth is driven by its superior biocompatibility and effectiveness in restoring vision. This segment is preferred for its ability to integrate seamlessly with human tissue, reducing the risk of rejection and complications. Advancements in harvesting techniques and preservation have further enhanced its viability, making it the gold standard in corneal transplants. The demand is also bolstered by increasing awareness among healthcare professionals and patients regarding its high success rates, especially for severe cases where artificial alternatives may not be as effective. This dominance is expected to continue as medical research refines techniques to expand the availability and usability of human donor corneas globally.

Analysis by Transplant Type:

  • Penetrating Keratoplasty
  • Endothelial Keratoplasty
  • Anterior Lamellar Keratoplasty
  • Keratoprosthesis

In 2025, penetrating keratoplasty held the largest market share because it effectively treats a variety of serious corneal disorders, such as degenerative diseases, thinning, and scarring. By substituting a healthy donor cornea for the injured or diseased cornea, this full-thickness corneal transplant technique provides a considerable improvement in eyesight. Its supremacy has been solidified by its wide range of applications and high success rate, especially when other methods, like lamellar keratoplasty, are less successful. Its use has been accelerated by improvements in surgical instruments and methods, which have increased accuracy and shortened recuperation periods. The demand for this technique is anticipated to continue to be strong in the upcoming years as patient and healthcare professional knowledge of it increases.

Analysis by Disease Indication:

  • Fuchs' Dystrophy
  • Fungal Keratitis
  • Keratoconus
  • Others

In 2025, Fuchs' dystrophy held the largest market share of 52.5%. Its high incidence in aging populations and the growing number of efficient treatment options are the main drivers of its rise. Surgery, such as corneal transplantation, is frequently required for this progressive eye condition, which causes corneal swelling and visual impairment. Advanced instances of Fuchs' dystrophy are frequently treated with penetrating keratoplasty and more recent methods such as Descemet's membrane endothelial keratoplasty (DMEK), which provide notable enhancements in visual acuity and quality of life. In order to maintain its market domination, the demand for therapies aimed at this ailment is being further fueled by improvements in surgical techniques and growing awareness of early detection.

Analysis by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Hospitals account for the largest market share of 57.5% in 2025. This growth is being fueled by their sophisticated infrastructure, access to state-of-the-art surgical tools, and availability of qualified ophthalmologists. In order to ensure high success rates and patient confidence, these institutes perform a majority of difficult corneal transplant operations, such as endothelial keratoplasty and penetrating keratoplasty. Additionally, hospitals play a key role in post-operative care by offering thorough monitoring and problem-solving services. Their position as the leading category has been further solidified by the rising healthcare investments to enhance hospital capacities and the increasing prevalence of corneal disorders. Furthermore, the increasing number of multispecialty hospitals adding state-of-the-art ophthalmology facilities guarantees continued demand in this industry.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2025, North America accounted for the largest market share of 50.5%. The high incidence of corneal disorders, a strong healthcare system, and large investments in medical research and innovation are the main drivers of this expansion. Superior treatment results are also made possible by the region's extensive access to qualified ophthalmologists and cutting-edge surgical technologies. Additionally, donor corneas are more accessible because of the encouraging organ and tissue donation programs. This, coupled with the acceptance of artificial corneas is accelerated by the existence of major market competitors. Favorable reimbursement policies and increasing awareness about advanced vision restoration procedures further contribute to North America's dominance. The United States, with its cutting-edge healthcare facilities and large patient base, remains the primary growth driver in the region.

Key Regional Takeaways:

United States Artificial Cornea and Corneal Implant Market Analysis

United States is leading the market with a share of 90.20% in North America. Aging population, the rising incidence of eye diseases, and advances in corneal implant technologies are some of the driving forces identified in the artificial cornea and corneal implant market in the US. According to the U.S. Census, the older population had already attained an impressive figure of 55.8 Million, or 16.8 percent of the total population, in 2020. With regards to increased number of elderly people, greater cases of eye diseases related to aging, such as cataracts and keratoconus, are inducing a need for corneal implants. Also, the increasing number of eye injuries and disorders owing to environmental factors further fuels the market. Technological innovations such as bioengineered corneas as well as artificial corneas are improving the outcomes and efficiency of corneal transplants. Adoption by the market is also enhanced by the availability of advanced diagnostic tools as well as improved surgical techniques. In addition, proper reimbursement policies and initiatives from healthcare providers are significant in increasing access to eye surgeries for their patients, which will be key in boosting this product market's growth. It is expected that awareness of and access to eye technologies, coupled with research in regenerative medicine, will drive the largest artificial cornea implant market forward, making the U.S. one of the biggest regions for implants.

Asia Pacific Artificial Cornea and Corneal Implant Market Analysis

The aging population, rising rates of corneal disorders, and improvements in healthcare infrastructure are contributing to the Asia-Pacific region's artificial cornea and corneal implant market's notable growth. The International Agency for the Prevention of Blindness (IAPB) reports that in Southeast Asia, East Asia, and Oceania, the age-standardized prevalence of blindness and moderate to severe visual impairment was greater in women than in men. Women are 12% more likely than males to lose their eyesight, and they make up 55% of the world's population with vision loss on average. As a result, corneal implants have become more popular among senior citizens. In addition, awareness about eye care and innovations in synthetic and bioengineered corneas are resulting in the growth of the market. With the improved healthcare infrastructure across the region, an increasing trend is expected to continue in the use of advanced eye care solutions in the Asia-Pacific region going forward.

Europe Artificial Cornea and Corneal Implant Market Analysis

Demographic changes, technology advancement and strong infrastructure for healthcare are the key factors which drive the artificial cornea and corneal implant market in Europe. As per the Confederation of WHO, currently nearly 90 million people living in the European Region have vision impairment or blindness, which covers almost 9% of the total population. The high incidence of eye diseases associated with an increasing older population is a considerable reason for the high demand for corneal implants. With the constant ageing of the population, there will also be an increase in the age-related eye diseases like cataracts and keratoconus. Certainly, there is a rise in the requirements for advanced treatment in relation to corneal health. Alongside this, the recent advances toward synthetic and bioengineered corneas have shown increased transplant success rates and are making corneal implants more effective and accessible. However, it is claimed that Europe has well-established healthcare systems along with strong awareness regarding eye health, that is boosting the market expansion. In addition, the region has provided continuous investment in eye care technologies and research in regenerative medicine. Therefore, the market for artificial corneas will continue to grow in the region as it is a key market for corneal implants because of favorable reimbursement policies and efforts to improve access to healthcare.

Latin America Artificial Cornea and Corneal Implant Market Analysis

Due to improved access to healthcare and the rising incidence of corneal disorders, the market for artificial corneas and corneal implants is expanding in Latin America. According to CEPAL, about 88.6 million persons in Latin America and the Caribbean were 60 years of age or older as of 2022, accounting for 13.4% of the region's total population. By 2030, this ratio is anticipated to rise to 16.5%. The need for sophisticated eye care, including corneal implant solutions, is growing because of the region's aging population, which is fueling the market's expansion.

Middle East and Africa Artificial Cornea and Corneal Implant Market Analysis

The region of the Middle East and Africa is experiencing demand for artificial and corneal implants due to increasing awareness of eye health as well as increasing cases of corneal diseases, with improvements in healthcare infrastructure. According to DUPHAT, between 0.8% in the UAE and 10.6% population in Turkey are exposed to chronic diseases, especially above the age of 60. This growing elderly population combined with a higher incidence of conditions such as trachoma accounts for a major reason for the demand of corneal implants. Additionally, advanced medical technologies that will continue developing and increased healthcare investments, are supporting the growth of the market.

Competitive Landscape:

Key players in the market are focusing on strategic innovations, partnerships, and expansions to strengthen their market position and meet the growing demand for advanced vision restoration solutions. Companies are heavily investing in R&D to develop biocompatible materials and next-generation implants that improve safety and effectiveness. Some are working on integrating advanced technologies, such as nanotechnology and bioengineered corneal tissues, to enhance product performance. Partnerships with healthcare providers and research institutions are enabling collaborative innovations and increasing the accessibility of these solutions. Key players are also expanding their geographical reach by entering emerging markets with high unmet needs, where awareness and access to advanced treatments are growing. In addition, efforts to improve the production and distribution of donor corneas through collaborations with eye banks are addressing critical supply shortages. These strategic moves are not only driving competition but also accelerating advancements in the field of corneal transplants and vision care.

The report provides a comprehensive analysis of the competitive landscape in the artificial cornea and corneal implant market with detailed profiles of all major companies, including:

  • AJL Ophthalmic S.A.
  • CorNeat Vision
  • Eye Care of San Diego
  • EyeYon Medical
  • KeraMed, Inc
  • LinkoCare Life Sciences AB
  • Lions World Vision Institute
  • LJ Eye Institute
  • Lv Prasad Eye Institute

Key Questions Answered in This Report

  • 1.What are artificial cornea and corneal implants?
  • 2.How big is the artificial cornea and corneal implant market?
  • 3.What is the expected growth rate of the global artificial cornea and corneal implant market during 2026-2034?
  • 4.What are the key factors driving the global artificial cornea and corneal implant market?
  • 5.What is the leading segment of the global artificial cornea and corneal implant market based on the type?
  • 6.What is the leading segment of the global artificial cornea and corneal implant market based on the transplant type?
  • 7.What is the leading segment of the global artificial cornea and corneal implant market based on the disease indication?
  • 8.What is the leading segment of the global artificial cornea and corneal implant market based on the end user?
  • 9.What are the key regions in the global artificial cornea and corneal implant market?
  • 10.Who are the key players/companies in the global artificial cornea and corneal implant market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Artificial Cornea and Corneal Implant Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Human Cornea
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Artificial Cornea
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Transplant Type

  • 7.1 Penetrating Keratoplasty
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Endothelial Keratoplasty
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Anterior Lamellar Keratoplasty
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Keratoprosthesis
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Disease Indication

  • 8.1 Fuchs' Dystrophy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Fungal Keratitis
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Keratoconus
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgical Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Specialty Clinics
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 AJL Ophthalmic S.A.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 CorNeat Vision
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Eye Care of San Diego
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 EyeYon Medical
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 KeraMed, Inc
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 LinkoCare Life Sciences AB
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Lions World Vision Institute
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 LJ Eye Institute
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Lv Prasad Eye Institute
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio

List of Figures

  • Figure 1: Global: Artificial Cornea and Corneal Implant Market: Major Drivers and Challenges
  • Figure 2: Global: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020-2025
  • Figure 3: Global: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 4: Global: Artificial Cornea and Corneal Implant Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Artificial Cornea and Corneal Implant Market: Breakup by Transplant Type (in %), 2025
  • Figure 6: Global: Artificial Cornea and Corneal Implant Market: Breakup by Disease Indication (in %), 2025
  • Figure 7: Global: Artificial Cornea and Corneal Implant Market: Breakup by End User (in %), 2025
  • Figure 8: Global: Artificial Cornea and Corneal Implant Market: Breakup by Region (in %), 2025
  • Figure 9: Global: Artificial Cornea and Corneal Implant (Human Cornea) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Artificial Cornea and Corneal Implant (Human Cornea) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Artificial Cornea and Corneal Implant (Artificial Cornea) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Artificial Cornea and Corneal Implant (Artificial Cornea) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Artificial Cornea and Corneal Implant (Penetrating Keratoplasty) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Artificial Cornea and Corneal Implant (Penetrating Keratoplasty) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Artificial Cornea and Corneal Implant (Endothelial Keratoplasty) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Artificial Cornea and Corneal Implant (Endothelial Keratoplasty) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Artificial Cornea and Corneal Implant (Anterior Lamellar Keratoplasty) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Artificial Cornea and Corneal Implant (Anterior Lamellar Keratoplasty) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Artificial Cornea and Corneal Implant (Keratoprosthesis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Artificial Cornea and Corneal Implant (Keratoprosthesis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Artificial Cornea and Corneal Implant (Fuchs' Dystrophy) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Artificial Cornea and Corneal Implant (Fuchs' Dystrophy) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Artificial Cornea and Corneal Implant (Fungal Keratitis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Artificial Cornea and Corneal Implant (Fungal Keratitis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Artificial Cornea and Corneal Implant (Keratoconus) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Artificial Cornea and Corneal Implant (Keratoconus) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Artificial Cornea and Corneal Implant (Other Diseases Indications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Artificial Cornea and Corneal Implant (Other Diseases Indications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Artificial Cornea and Corneal Implant (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Artificial Cornea and Corneal Implant (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Artificial Cornea and Corneal Implant (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Artificial Cornea and Corneal Implant (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Artificial Cornea and Corneal Implant (Specialty Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Artificial Cornea and Corneal Implant (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: North America: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: North America: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: United States: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: United States: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Canada: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Canada: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Asia-Pacific: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Asia-Pacific: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: China: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: China: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Japan: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Japan: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: India: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: India: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: South Korea: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: South Korea: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Australia: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Australia: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: Indonesia: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: Indonesia: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Others: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Others: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: Europe: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: Europe: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: Germany: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: Germany: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: France: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: France: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: United Kingdom: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: United Kingdom: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Italy: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Italy: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Spain: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Spain: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Russia: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Russia: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Others: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: Others: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: Latin America: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: Latin America: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Brazil: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Brazil: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Mexico: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Mexico: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Others: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Others: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Middle East and Africa: Artificial Cornea and Corneal Implant Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Middle East and Africa: Artificial Cornea and Corneal Implant Market: Breakup by Country (in %), 2025
  • Figure 83: Middle East and Africa: Artificial Cornea and Corneal Implant Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 84: Global: Artificial Cornea and Corneal Implant Industry: SWOT Analysis
  • Figure 85: Global: Artificial Cornea and Corneal Implant Industry: Value Chain Analysis
  • Figure 86: Global: Artificial Cornea and Corneal Implant Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Artificial Cornea and Corneal Implant Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Artificial Cornea and Corneal Implant Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Artificial Cornea and Corneal Implant Market Forecast: Breakup by Transplant Type (in Million USD), 2026-2034
  • Table 4: Global: Artificial Cornea and Corneal Implant Market Forecast: Breakup by Disease Indication (in Million USD), 2026-2034
  • Table 5: Global: Artificial Cornea and Corneal Implant Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 6: Global: Artificial Cornea and Corneal Implant Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Artificial Cornea and Corneal Implant Market: Competitive Structure
  • Table 8: Global: Artificial Cornea and Corneal Implant Market: Key Players